Agitation

Agitation: What is it?
- This seems like a silly question, but the literature does not use a consistent definition. [Sonnier, 2011]
- Most definitions include behavior that may lead to harm to the patient or healthcare providers if no intervention is taken.
Agitation: Common?
- Estimated that 10-20% of children and adolescents have mental disorders and/or substance abuse.
- ED visits for psychiatric conditions in children continue to increase. [Pittsenbarger, 2014]
- The resources required to care for pediatric patients needing psychiatric care in the ED continues to increase also. [Sheridan, 2015]
- During psychiatric evaluation, about 1 out 15 of kids required restraint. [Dorfman, 2006]
Agitation: What is it due to?
- This question is incredibly important to address.
- Similar to the trauma patient, do not get distracted by the obvious injury and overlook the more substantial, occult one.
- Violent behavior may be why the patient is in the ED, but think of it as a symptom rather than the diagnosis.
- The acutely agitated patient is not a “psychiatric patient” until you’ve consider the other emergent medical conditions.
- Undifferentiated agitation (abridged) Ddx:
- Broad Categories:
- Medical Conditions
- Substance Use
- Psychiatric illness
- AEIOU TIPS (yes… this is the one for Altered Mental Status… I’m not smart enough to remember more than one acronym)
- Alcohol – while often a sedative, ETOH can cause agitation
- Electrolyte derangements (ex, hyponatremia, hypercalcemia)
- Insulin (got hypoglycemia??)
- Opiates and Other Drugs (got a toxidrome? anticholinergic vs sympathomimetic? NMS? Serotonin syndrome?)
- Uremia
- Trauma – Look closely for signs of trauma
- Infection – Meningitis/encephalitis?
- Psychiatric disorder – really should be the last one considered
- Space occupying lesion
- While each year a new set of “designer” intoxicants may be added to the list, don’t become enamored with them and forget more “boring” entities (ex, hypoglycemia!).
- Broad Categories:
Agitation: Management?
- Primary Goal = keep patient and staff safe while allowing continued evaluation.
- The least restrictive method that attains this goal should be used. [Adimando, 2010]
- Unfortunately, how to safely restrain pediatric patients is not often taught. [Dorfman, 2004]
- If not immediately dangerous, attempt simple, nonrestrictive strategies: [Adimando, 2010]
- Verbal de-escalation
- Reduction of environmental stimuli (a quite room is much better than a loud hallway)
- Offer basic needs (ex, food, warm blanket)
- If simple tactics don’t work, or the patient is initially dangerous, move onward to restraint.
- Ideally, before selecting a medication, the etiology would be known so risk could be minimized…
- In reality, evaluation and management occur concurrently, so some Rx options may be less desirable in the undifferentiated acutely agitated patient.
-
“Chemical Restraint”
- Oral vs Intramuscular
- If the patient is cooperative, offer oral medications first.
- May give the patient sense of some control.
- Avoid trauma of being physically restrained for IM shot
- Many medications are equally effective in oral form
- If patient is not cooperative, the oral route is not going to be an option.
- If the patient is cooperative, offer oral medications first.
- There is no perfect medication option for every scenario, and the true efficacy of the various options is unknown in children, so be conservative and keep a few options in mind: [Carubia, 2016]
- Benzodiazepines
- Lorazepam – 0.05-0.1 mg/kg/dose (PO/IM/IV)
- Midazolam – 0.25-0.5 mg/kg/dose PO; 0.2-0.3 mg/kg IN; 0.1-0.15 mg/kg/dose IM
- First Generation Antipsychotics
- Haloperidol – 0.5-5 mg PO; 0.05-0.15 mg/kg IM (up to 5 mg/dose)
- Droperidol – 0.03-0.07 mg/kg/dose (IM/IV)
- Has become scarce in the USA after FDA black-box warning regarding QT prolongation — which other antipsychotics cause as well (some even more so)
- Has been shown to be safe and effective for acute agitation in pediatric patients in ED setting. [Szwak, 2010]
- Chlorpromazine – 0.55 mg/kg/dose (PO/IM)
- Second Generation Antipsychotics
- Risperidone – 0.25-2 mg PO/ODT
- Olanzapine – 2.5-5 mg PO/ODT
- Others:
- Diphenhydramine – 1 mg/kg/dose (PO/IM)
- Ketamine (ok, so I’m biased, but this is awesome!) [Kowalski, 2015]
- Rapid onset due to high bioavailability (even when given IM)
- No QT prolongation issues
- Safe even in overdose (important when you aren’t sure of patient weight)
- No respiratory depression (rarely, may see laryngospasm)
- Should likely avoid in patient with known schizophrenia
- Benzodiazepines
- Oral vs Intramuscular
-
Physical Restraints
- Can be dangerous (i.e., Rhabdomyolysis and Airway compromise), but there are safe methods to use.
- Use as last option
- Remove as soon as no longer needed
Moral of the Morsel
- Acutely agitated patients can be hazardous to themselves and the entire ED; anticipate how you will deal with them (because eventually one will be requiring your acute attention).
- Acute agitation is a symptom — look for the cause while keeping everyone safe.
- Consider non-restrictive means to controlling the situation first, if possible.
- There is no perfect medication that is good for every scenario and patient — keep several in your tool belt.
References
Carubia B1,2, Becker A3,4, Levine BH5. Child Psychiatric Emergencies: Updates on Trends, Clinical Care, and Practice Challenges. Curr Psychiatry Rep. 2016 Apr;18(4):41. PMID: 26932516. [PubMed] [Read by QxMD]
Sheridan DC1, Spiro DM, Fu R, Johnson KP, Sheridan JS, Oue AA, Wang W, Van Nes R, Hansen ML. Mental Health Utilization in a Pediatric Emergency Department. Pediatr Emerg Care. 2015 Aug;31(8):555-9. PMID: 25834957. [PubMed] [Read by QxMD]
Kowalski JM1, Kopec KT, Lavelle J, Osterhoudt K. A Novel Agent for Management of Agitated Delirium: A Case Series of Ketamine Utilization in the Pediatric Emergency Department. Pediatr Emerg Care. 2015 Oct 13. PMID: 26466151. [PubMed] [Read by QxMD]
Pittsenbarger ZE1, Mannix R. Trends in pediatric visits to the emergency department for psychiatric illnesses. Acad Emerg Med. 2014 Jan;21(1):25-30. PMID: 24552521. [PubMed] [Read by QxMD]
Sonnier L1, Barzman D. Pharmacologic management of acutely agitated pediatric patients. Paediatr Drugs. 2011 Feb 1;13(1):1-10. PMID: 21162596. [PubMed] [Read by QxMD]
Adimando AJ1, Poncin YB, Baum CR. Pharmacological management of the agitated pediatric patient. Pediatr Emerg Care. 2010 Nov;26(11):856-60; quiz 861-3. PMID: 21057285. [PubMed] [Read by QxMD]
Szwak K1, Sacchetti A. Droperidol use in pediatric emergency department patients. Pediatr Emerg Care. 2010 Apr;26(4):248-50. PMID: 20401969. [PubMed] [Read by QxMD]
Barzman DH1, DelBello MP, Forrester JJ, Keck PE Jr, Strakowski SM. A retrospective chart review of intramuscular ziprasidone for agitation in children and adolescents on psychiatric units: prospective studies are needed. J Child Adolesc Psychopharmacol. 2007 Aug;17(4):503-9. PMID: 17822344. [PubMed] [Read by QxMD]
Dorfman DH1, Kastner B. The use of restraint for pediatric psychiatric patients in emergency departments. Pediatr Emerg Care. 2004 Mar;20(3):151-6. PMID: 15094571. [PubMed] [Read by QxMD]
Sorrentino A1. Chemical restraints for the agitated, violent, or psychotic pediatric patient in the emergency department: controversies and recommendations. Curr Opin Pediatr. 2004 Apr;16(2):201-5. PMID: 15021203. [PubMed] [Read by QxMD]




Hi Sean — Thanks for the wonderful review! I noticed that Ziprasidone (Geodon) was not included on your list. What are your thoughts on this med? My limited experience with it is that although it takes a few minutes to reconstitute (tough in acute situations), it has less QTc prolongation that the 1st gen antipsychotics. Thanks for fielding the question!
Seth, great question! I personally like to use it in adults, but the literature for children and ziprasidone is not that supportive. This is why I left it off. In time, this information may change.
Hope you are well!
Have a great day,
Sean